In Argentina, livestock producers are facing a vaccination crisis as they claim they are being forced to use a more expensive foundation for foot-and-mouth disease vaccines.
As Argentina intensifies its vaccination campaign against foot-and-mouth disease, a significant conflict has emerged among livestock producers in the western province of Buenos Aires. The Rural Association of Salliqueló (ARS) has highlighted a concerning discrepancy in vaccination costs, explaining that producers in Salliqueló are charged $1750 per dose, whereas those in the neighboring district of Adolfo Alsina, through the Foundation for Animal Health (Fuaasa), must pay $2400 per dose—a difference of nearly 40%. This financial burden has led producers to feel 'captive' to this foundation, prompting them to seek alternatives for vaccination based on cost efficiency.
The ARS has called for regulatory intervention from Senasa (National Service of Agrifood Health and Quality) to allow producers in neighboring areas to choose their vaccine provider. The situation reveals broader issues within the vaccination framework as the local producers argue that a lack of competition contributes to inflated prices. The ongoing vaccination initiative is critical for the regional livestock sector, aiming to control foot-and-mouth disease, which can have devastating effects on cattle and farming communities.
Producers emphasize that enabling open competition in vaccine provision could lead to fairer pricing and more efficient vaccination efforts. They argue that the current structure not only hampers their economic sustainability but also undermines the effectiveness of the disease control campaign. As voices of concern grow among local producers and with the vaccination campaign underway, the implications of this conflict could potentially impact livestock health and market stability in the region.
